Suyi Li

First-line serplulimab or placebo plus chemotherapy in PD-L1-positive esophageal squamous cell carcinoma: a randomized, double-blind phase 3 trial

Yan Song, Bo Zhang, Dao Xin et al. · Nature Medicine · 2023 · 169 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Multifunctional tacrine–flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease

Suyi Li, Xiaobing Wang, Sai‐Sai Xie et al. · European Journal of Medicinal Chemistry · 2013 · 96 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Design, synthesis and evaluation of novel tacrine–rhein hybrids as multifunctional agents for the treatment of Alzheimer's disease

Suyi Li, Neng Jiang, Sai‐Sai Xie et al. · Organic & Biomolecular Chemistry · 2013 · 93 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer’s disease

Jinshuai Lan, Sai‐Sai Xie, Suyi Li et al. · Bioorganic & Medicinal Chemistry · 2014 · 76 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Inhibition of Tumor Growth in Vitro by a Combination of Extracts from Rosa Roxburghii Tratt and Fagopyrum Cymosum

Wei Liu, Suyi Li, Xin‐En Huang et al. · Asian Pacific Journal of Cancer Prevention · 2012 · 75 citations · Full text

Medicine, Oncology, Pharmacology +16